Literature DB >> 1648234

Differentiation between two distinct classes of viruses now classified as human herpesvirus 6.

E C Schirmer1, L S Wyatt, K Yamanishi, W J Rodriguez, N Frenkel.   

Abstract

Human herpesvirus 6 (HHV-6) causes exanthem subitum (ES, roseola infantum), a childhood disease characterized by high fever and skin rash. We have analyzed restriction enzyme cleavage patterns of the DNAs of ES virus isolates from Japan and the United States. The patterns of all the ES viral DNAs were highly conserved, except for variable sequences within the terminal repeat sequences. They resembled closely the restriction enzyme patterns of the Z29 strain of HHV-6 but were distinct from those of the U1102 strain. That all ES isolates were closely related whereas the U1102 patterns were very different suggests that the U1102 strain represents a distinct virus. Moreover, the ES isolates all resembled the Z29 strain and not the U1102 strain with respect to reactivity with HHV-6 monoclonal antibodies. These findings provide evidence for the existence of two distinct classes of viruses previously classified as HHV-6. Whereas the Z29-like viruses are involved in ES infections, the association of the U1102-like viruses with human disease has yet to be determined.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1648234      PMCID: PMC51990          DOI: 10.1073/pnas.88.13.5922

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Viral pathology of human herpesvirus 6 infection.

Authors:  T Kurata; T Iwasaki; T Sata; T Wakabayashi; K Yamaguchi; T Okuno; K Yamanishi; Y Takei
Journal:  Adv Exp Med Biol       Date:  1990       Impact factor: 2.622

2.  Genomic heterogeneity of human herpesvirus 6 isolates.

Authors:  P E Pellett; G J Lindquester; P Feorino; C Lopez
Journal:  Adv Exp Med Biol       Date:  1990       Impact factor: 2.622

3.  Exanthem subitum and human herpesvirus 6 (HHV-6) infection.

Authors:  K Yamanishi; T Kondo; K Kondo; Y Hayakawa; S Kido; K Takahashi; M Takahashi
Journal:  Adv Exp Med Biol       Date:  1990       Impact factor: 2.622

4.  New T-lymphotropic human herpesviruses.

Authors:  W B Becker; S Engelbrecht; M L Becker; C Piek; B A Robson; L Wood; P Jacobs
Journal:  Lancet       Date:  1989-01-07       Impact factor: 79.321

5.  Genomic analysis of the human B-lymphotropic virus (HBLV).

Authors:  S F Josephs; S Z Salahuddin; D V Ablashi; F Schachter; F Wong-Staal; R C Gallo
Journal:  Science       Date:  1986-10-31       Impact factor: 47.728

6.  Exanthem subitum and antibody to human herpesvirus-6.

Authors:  K Ueda; K Kusuhara; M Hirose; K Okada; C Miyazaki; K Tokugawa; M Nakayama; K Yamanishi
Journal:  J Infect Dis       Date:  1989-04       Impact factor: 5.226

7.  Frequent shedding of human herpesvirus 6 in saliva.

Authors:  G B Harnett; T J Farr; G R Pietroboni; M R Bucens
Journal:  J Med Virol       Date:  1990-02       Impact factor: 2.327

8.  Antibody reactivity with HBLV (HHV-6) in U.S. populations.

Authors:  C Saxinger; H Polesky; N Eby; S Grufferman; R Murphy; G Tegtmeir; V Parekh; S Memon; C Hung
Journal:  J Virol Methods       Date:  1988-09       Impact factor: 2.014

9.  Brief report: primary human herpesvirus 6 infection in a patient following liver transplantation from a seropositive donor.

Authors:  K N Ward; J J Gray; S Efstathiou
Journal:  J Med Virol       Date:  1989-06       Impact factor: 2.327

10.  Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders.

Authors:  S Z Salahuddin; D V Ablashi; P D Markham; S F Josephs; S Sturzenegger; M Kaplan; G Halligan; P Biberfeld; F Wong-Staal; B Kramarsky
Journal:  Science       Date:  1986-10-31       Impact factor: 47.728

View more
  62 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Viral gene expression patterns in human herpesvirus 6B-infected T cells.

Authors:  Bodil Øster; Per Höllsberg
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

3.  Disease association and diagnosis of human herpesvirus 6.

Authors:  J Weber; G Wilson
Journal:  Can J Infect Dis       Date:  1994-07

4.  Induction of cell-cell fusion from without by human herpesvirus 6B.

Authors:  Simon Metz Pedersen; Bodil Oster; Bettina Bundgaard; Per Höllsberg
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

Review 5.  The family Herpesviridae: an update. The Herpesvirus Study Group of the International Committee on Taxonomy of Viruses.

Authors:  B Roizmann; R C Desrosiers; B Fleckenstein; C Lopez; A C Minson; M J Studdert
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

6.  Phenotypic and functional alterations of dendritic cells induced by human herpesvirus 6 infection.

Authors:  Miki Kakimoto; Atsuhiko Hasegawa; Shigeru Fujita; Masaki Yasukawa
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Identification and mapping of the gene encoding the glycoprotein complex gp82-gp105 of human herpesvirus 6 and mapping of the neutralizing epitope recognized by monoclonal antibodies.

Authors:  B Pfeiffer; Z N Berneman; F Neipel; C K Chang; S Tirwatnapong; B Chandran
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

8.  Human herpesvirus 6 open reading frame U12 encodes a functional beta-chemokine receptor.

Authors:  Y Isegawa; Z Ping; K Nakano; N Sugimoto; K Yamanishi
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  The DR1 and DR6 first exons of human herpesvirus 6A are not required for virus replication in culture and are deleted in virus stocks that replicate well in T-cell lines.

Authors:  Ronen Borenstein; Haim Zeigerman; Niza Frenkel
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

10.  Use of amplicon-6 vectors derived from human herpesvirus 6 for efficient expression of membrane-associated and -secreted proteins in T cells.

Authors:  Ronen Borenstein; Oded Singer; Adi Moseri; Niza Frenkel
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.